on Heard Island (53#{176}01 S,73#{176}23 E) and required the seals to be immobilized once for at least 30 mm. The second part

Similar documents
EFFECTS OF PHYSIOLOGICAL STATE ON DURATION OF SEDATION IN SOUTHERN ELEPHANT SEALS

T u l a n e U n i v e r s i t y I A C U C Guidelines for Rodent & Rabbit Anesthesia, Analgesia and Tranquilization & Euthanasia Methods

SUMMARY OF PRODUCT CHARACTERISTICS

STANDARD OPERATING PROCEDURE #111 RAT ANESTHESIA

These are the topics typically covered in GWR courses All labs with live animals have been approved by several Animal Care and Use Committees.

6/10/2015. Multi Purpose Canine (MPC) Restraint and Physical Examination PFN: Terminal Learning Objective. Hours: Instructor:

A New Advancement in Anesthesia. Your clear choice for induction.

NUMBER: R&C-ARF-10.0

DISSOCIATIVE ANESTHESIA

BOX 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Hymatil 300 mg/ml solution for injection for cattle and sheep Tilmicosin

Dexmedetomidine and its Injectable Anesthetic-Pain Management Combinations

SUMMARY OF PRODUCT CHARACTERISTICS

STANDARD OPERATING PROCEDURE #110 MOUSE ANESTHESIA

Anesthetic regimens for mice, rats and guinea pigs

Summary of Product Characteristics

NUMBER: /2005

Day 90 Labelling, PL LABELLING AND PACKAGE LEAFLET

DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS

SUMMARY OF PRODUCT CHARACTERISTICS

This SOP presents commonly used anesthetic regimes in rabbits.

PROTOCOL FOR ANIMAL USE AND CARE

The UCD community has made this article openly available. Please share how this access benefits you. Your story matters!

Mouse Formulary. The maximum recommended volume of a drug given depends on the route of administration (Formulary for Laboratory Animals, 3 rd ed.

Candidate Name: PRACTICAL Exercise Medications & Injections

1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT

Procedure # IBT IACUC Approval: December 11, 2017

ANTAGONISM OF XYLAZINE HYDROCHLORIDE KETAMINE HYDROCHLORIDE IMMOBILIZATION IN GUINEAFOWL (NUMIDA MELEAGRIS) BY YOHIMBINE HYDROCHLORIDE

GUIDELINES FOR ANESTHESIA AND FORMULARIES

SUMMARY OF PRODUCT CHARACTERISTICS

DEPOSEL Slow Release Selenium Injection for Cattle and Sheep

SURGICAL (SURVIVAL) OOCYTE COLLECTION FROM XENOUS LAEVIS

FWC Division of Law Enforcement

Mass Delivery of Nonsurgical Sterilants

POST-OPERATIVE ANALGESIA AND FORMULARIES

EUTHANASIA OF DOGS (Photos courtesy of KwaZulu-Natal Rabies Project and World Animal Protection)

B. PACKAGE LEAFLET 1

SUMMARY OF PRODUCT CHARACTERISTICS. NUFLOR 300 mg/ml solution for injection for cattle and sheep

Biohazard: yes no Radioisotopes: yes no Chemical Carcinogen: yes no Agent: Agent: Agents: Project Title: Objective:

Anaesthesia and Analgesia of fish

Health Products Regulatory Authority

CO Oguntoye* & BO Oke

SUMMARY OF PRODUCT CHARACTERISTICS

PFIZER ANIMAL HEALTH Product Name: LINCO-SPECTIN"" ANTIBIOTIC INJECTABLE SOLUTION Date: 1 November 2011 Page 1 of 9

PROTOCOL #_10546 EXPIRES: 5/22/04

PROTOCOL FOR THE HUMANE CARE AND USE OF LIVE VERTEBRATE ANIMALS

SUMMARY OF PRODUCT CHARACTERISTICS. Pentoject, Pentobarbitone Sodium 200 mg/ml Solution for Injection

Summary of Product Characteristics

SUMMARY OF PRODUCT CHARACTERISTICS

Perioperative Care of Swine

Field Immobilization of Raccoons (Procyon lotor) with Telazol and Xylazine

USA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only

SUMMARY OF PRODUCT CHARACTERISTICS. Euthasol vet. 400 mg/ml, solution for injection (AT, BE, DK, EE, EL, FI, IE, IS, LT, LU, LV, NO, PL, RO SE, UK)

Alfaxan. (alfaxalone 10 mg/ml) Intravenous injectable anesthetic for use in cats and dogs. TECHNICAL NOTES DESCRIPTION INDICATIONS

SUMMARY OF PRODUCT CHARACTERISTICS

Standing sedation with medetomidine and butorphanol in captive African elephants (Loxodonta africana)

The problems with oxytocin alone

PENGUINS. Marine Discovery Centre, Henley Beach, S.A. MDC 1

UNIVERSITY OF PITTSBURGH Institutional Animal Care and Use Committee

Australian and New Zealand College of Veterinary Scientists. Fellowship Examination. Veterinary Anaesthesia and Critical Care Paper 1

Title of Procedure: Rumen Cannulation (Sheep, Goats & Cattle) (L12)

A. BACKGROUND INFORMATION

SUMMARY OF PRODUCT CHARACTERISTICS

ANIMAL CARE AND USE STANDARD

SUMMARY OF PRODUCT CHARACTERISTICS. Narcostart 1 mg/ml solution for injection for cats and dogs (NL, AT, BE, CZ, EL, HU, IS, LU, PL, SK)

ZOETIS INC. 333 PORTAGE STREET, KALAMAZOO, MI, Telephone: Customer Service: Website: EXCEDE FOR SWINE

DOG CHEMICAL & NON-CHEMICAL CAPTURE AND HANDLING Maximizing Success and Minimizing the Fight For Animal Control Officers

Summary of Product Characteristics

EVALUATION OF EPIDURAL ANAESTHESIA WITH LIGNOCAINE XYLAZINE MIXTURE IN KETAMINE SEDATED CATS

EXCEDE Sterile Suspension

SUMMARY OF PRODUCT CHARACTERISTICS

Online Early Version

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX III LABELLING AND PACKAGE LEAFLET

Pain Management in Racing Greyhounds

Department of Laboratory Animal Resources. Veterinary Recommendations for Anesthesia and Analgesia

Induction of a Transient Chemically Induced Lameness in the Sow. Detection Using a Prototype Embedded Micro-computerbased Force Plate System

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

ISMP Canada HYDROmorphone Knowledge Assessment Survey

UiTM CARE APPLICATION FORM

REVISED PROPOSED REGULATION OF THE NEVADA STATE BOARD OF VETERINARY MEDICAL EXAMINERS. LCB File No. R June 9, 2003

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Regional and Local Anesthesia of the Wrist and Hand Aided by a Forearm Sterile Elastic Exsanguination Tourniquet - A Review

MARKING SOUTHERN ELEPHANT SEALS ON ILES KERGUELEN

Feline blood transfusions: preliminary considerations

SINGLE ANNUAL IMPLANT

SUMMARY OF PRODUCT CHARACTERISTICS. 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Emdocam 20 mg/ml solution for injection for cattle, pigs and horses

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Chapter 59 Wound Management Principles

Cydectin. Fort Dodge PRODUCT DESCRIPTION

Summary of Product Characteristics

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT FAULKNER STATE COMMUNITY COLLEGE

SUMMARY OF PRODUCT CHARACTERISTICS. Bottle of powder: Active substance: ceftiofur sodium mg equivalent to ceftiofur...

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

7/25/2014. Proper Injection Technique. Review Pork Quality Assurance Plus. Contact Information. Why are injections given?

Proceedings of the International Congress of the Italian Association of Companion Animal Veterinarians

Behavioral responses following eight anesthetic induction protocols in horses

APPLICATION FOR LIVE ANIMAL USE IN TEACHING AT COASTAL ALABAMA COMMUNITY COLLEGE

Reduce the risk of recurrence Clear bacterial infections fast and thoroughly

Withdrawal period: 93 days Milk: Not authorised for use in animals producing milk for human consumption.

USE OF MEDETOMIDINE HYDROCHLORIDE AS SEDATIVE IN CATTLE CALVES

Transcription:

Journal of Wildlife Diseases, 23(4), 1987, pp. 614-618 Wildlife Disease Association 1987 PROLONGED AND MULTIPLE IMMOBILIZATIONS OF THE SOUTHERN ELEPHANT SEAL USING KETAMINE HYDROCHLORIDE-XYLAZINE HYDROCHLORIDE OR KETAMINE HYDROCHLORIDEDIAZEPAM COMBINATIONS Nicholas J. Gales and Harry R. Burton Biology Section, Antarctic Division, Department of Science, Channel Highway, Kingston, Tasmania, Australia 7150 ABSTRACT: Thirty seven southern elephant seals (Mirounga leonina) were singularly or repeatedly immobilized with combinations of ketamine hydrochloride (HCI) and xylazmne HC1 or ketamine HC1 and diazepam. Atropine sulphate was included in the drug combinations. To permit experimental procedures the seals were immobilized for periods of 30-330 mm. The mean induction dose of ketamine HC1 was 8.71 ± 0.25 mg/kg (mean ± SE). The mean induction time was 16.02 ± 2.62 mm. For the elephant seals immobilized for periods in excess of 180 mm, the mean dose of ketamine HC1 used per hr was 3.31 ± 0.13 mg/kg/hr and the mean dose of ketamine HC1 used per hr postinduction was 1.31 ± 0.15 mg/kg/hr. The mean dose of diazepam used was 0.09 ± 0.01 mg/kg and the mean dose of xylazine HC1 was 0.41 ± 0.01 mg/kg. Elephant seals were weighed on 20 occasions (weight range: 897-1,932 kg) and the relationship between standard length and weight was found to be: Weight = 9.98 length - 2,317.63 (r2 = 0.724). Adverse reactions to seals immobilized only once or twice were not observed. Two seals immobilized on three occasions developed abscesses at the site of injection. Key words: Southern elephant seal, Mirounga leonina, ketamine hydrochloride, xylazine hydrochloride, diazepam, immobilization. INTRODUCTION Safe, rapid and repeatable methods of restraining animals in the field are an invaluable tool for wildlife researchers. As more detailed hands on studies are being conducted on seals in the Antarctic the development of a safe and effective anesthetic is becoming more important. Ketamine hydrochloride (HC1), used alone or in conjunction with xy!azine HC1 or diazepam, has been shown to be a relatively safe method of immobilizing seals for short periods (Briggs et a!., 1975; Geraci et al., 1981; Parry et a!., 1981; Ryding, 1982; Trillmich, 1983; Gales, 1984; Baker and Gatesman, 1985). Repeated immobilizations of individuals have been reported by Geraci et a!. (1981) and Parry et a!. (1981). As part of a study into the role of subcutaneous fat (Gales and Burton, 1987) 37 southern elephant seals (Mirounga leonina) were immobilized during the spring and summer of 1985-1986. The study was divided into two parts. The first was conducted on Heard Island (53#{176}01 S,73#{176}23 E) and required the seals to be immobilized once for at least 30 mm. The second part was conducted at the Vestfold Hills, Antarctica (68#{176}30 S,78#{176}00 E) and required the seals to be immobilized up to three times for periods of over 4 hr. This paper reports the use of ketamine HC1, in conjunction with xylazine HC! or diazepam, to immobilize southern elephant seals in single or multiple episodes for prolonged periods. MATERIALS AND METHODS The standard length (straight line measurement from the tip of the proboscis to the tip of the tail) for each seal was estimated and an approximate weight calculated using the regression equation from Ling and Bryden (1981). These weights were used to calculate the drug dose. Initially, the dose rates of ketamine HC1, diazepam and xylazine HC1 were based on those suggested for use in pinnipeds (Briggs et al., 1975; Geraci et a!., 1981; Parry et a!., 1981; Ryding, 1982; Trillmich, 1983; Gales, 1984; Baker and Gatesman, 1985), but were modified when it became apparent that a deeper plane 614

GALES AND BURTON-IMMOBILIZATION OF SOUTHERN ELEPHANT SEALS 615 of anesthesia was required for rolling the animals over and weighing them. Atropine sulphate was added to the basic drug mixture to decrease secretions into the respiratory tract. The calculated dose of ketamine HC1 (solution strength 186 mg/ml) (Parke Davis, Sydney, Australia) and atropine sulphate (0.65 mg/ml) ( Parnell Laboratories, Kirrawee, New South Wales, Australia) was mixed with diazepam (5 mg/ml) (Valium#{174}, Roche Products Pty Ltd, Sydney, Australia) or xylazmne HC1 (20 mg/ml) (Rompun#{174}, Bayer, Australia) in a 60-ml syringe and was administered intramuscularly in the lumbar region. The technique of administration described by Ryding (1982) was followed. It utilized approximately 300 cm of intravenous drip tubing and a 90-mm x 18-gauge spinal needle. The drugs were flushed through the tubing using up to 50 ml of sterile water. If immobilization had not occurred within 10 mm an additional dose of ketamine HC1 was administered. Induction time was recorded as the period between injection and failure of the animal to raise its head when patted on the back. Duration of immobilization was recorded as the interval from the end of induction to the time when the animal regained the ability to resist being handled. Although respiratory rate and heart rate were not systematically recorded, they were checked and any abnormalities noted. During October and November 1985 14 male and 13 female elephant seals were immobilized on Heard Island. Males were selected from bachelor class animals (n = 5) (Carrick et al., 1962) found on the periphery of the harems, or from subadult animals arriving after the breeding season to begin their annual moult (n = 8). One male weaned pup was immobilized also. The female seals, four of which were preparturient, eight lactating, and one which had already weaned her pup, were selected from the breeding harems. The animals were not weighed. From February to April 1986 10 bachelor class males were immobilized along the coast of the Vestfold Hills, Antarctica. These seals were part of a predominantly male prebreeding age group of seals that migrate annually to the Vestfold Hills to moult (Ingham, 1957; Tierney, 1977). Two of these seals were immobilized on three occasions, six were immobilized twice and two were immobilized once. The seals were identified with the use of plastic flipper tags (Jumbo Rototags, Dalton Supplies, Henley-on- Thames, England). To permit experimental procedures, immobilization was maintained for 240 mm. After the initial dose of anesthetic the seal was observed and additional doses of ketamine HC1 were given to effect. These doses were given by intramuscular injection into the lumbar muscles or intravenous injection into the extradural vein. The animals were weighed during the immobilization, among other procedures. Five people were required to roll the seals onto a sling constructed of two aluminum poles (external diameter, 50 mm; internal diameter, 42 mm), each 4 m long, between which woven nylon strapping (car seat belt webbing) was slung. A tripod, constructed of hinged aluminum scaffold planking 5 m in height, was erected above the animal lying on the sling in ventral recumbency. A 2.5-ton capacity block and tackle was used to suspend the seal from a 2-ton capacity spring scale with a dial readout (Salter, Staffordshire, England). RESULTS The mean induction dose of ketamine HC1 was 8.71 ± 0.25 mg/kg (mean ± SE) (range = 5.40-12.50 mg/kg). The mean induction time was 16.02 ± 2.62 mm (range = 5-70 mm). The mean dose of ketamine HC1 used per hr (taken as the total amount of ketamine HC1 used divided by the period from injection to recovery) was 3.31 ± 0.13 mg/kg/hr (range = 2.38-3.97 mg/kg/hr) for the seals at the Vestfold Hills and 11.49 ± 0.79 mg/kg/ hr (range = 3.75-18.2) for the Heard Island seals. The mean postinduction dose of ketamine HC1 used per hr (taken as the difference between the total amount of ketamine HC1 used and the induction dose, divided by the duration of immobilization) was 1.31 ± 0.15 mg/kg/hr (range = 0-2.50 mg/kg/hr) for the seals immobilized for prolonged periods. For each mg of ketamine HC1 given per kg of seal the average recovery time was 6.22 ± 0.57 mm (range = 3.37-16.00) for the Heard Island seals and 18.05 ± 0.86 mm (range = 8.30-25.25) for the seals from the Vestfold Hills. The mean dose of diazepam used was 0.09 ± 0.01 mg/kg (range = 0.03-1.02) and the mean dose of xylazine HC1 was 0.41 ± 0.01 mg/kg (range = 0.24-0.85). On Heard Island eight seals required several injections of anesthetic to attain a sufficient degree of immobilization; the remainder (n = 19) required only one injec-

616 JOURNAL OF WILDLIFE DISEASES, VOL. 23, NO. 4, OCTOBER 1987 tion. All injections were given intramuscularly. At the Vestfold Hills six seals required up to four injections of ketamine HC1 before induction was achieved; the remainder (n = 14) required only one injection. Ten injections of ketamine HC1 were administered intravenously, the remaining 60 were given intramuscularly. An average of 3.5 injections of ketamine HC! per seal was required for each anesthetic episode to maintain immobilization for approximately 240 mm. One elephant seal, anesthetized for the second time 13 days after the first immobilization with a dose of 8.20 mg/kg of ketamine HC1 and 0.04 mg/kg of diazepam, died 5 mm postinjection. The induction time of the anesthetic was less than 30 sec and before death the seal was apnoeic and exhibited a marked bradycardia. Two seals developed clinical lesions consistent with abscess formation. These were the two seals immobilized on three occasions. On one seal (89) the lesion formed in the area directly overlying the lumbar vertebrae. This was the site of venipuncture for blood sampling and intravenous injection of additional anesthetic. This animal was unable to use its hind flippers for approximately 2 wk. The other seal (167) developed an abscess at the site used for intramuscular injections. The abscesses in both seals healed within 3 wk, but both seals remained at the moult site for considerably longer than other individuals. Slight muscular tremors were observed to last for approximately 3 mm in one seal. Signs of respiratory distress were not observed in any animals and, except for the single mortality, all seals recovered from anesthesia uneventfully. The average estimated body weight of the seals anesthetized on Heard Island was 465 ± 53 kg (range = 192-1,102 kg). The average body weight of seals weighed at the Vestfold Hills was 1,477 ± 61 kg (range = 897-1,932 kg). The relationship between body weight and standard length for the elephant seals at the Vestfold Hills was: Weight = 9.98 length - 2,317.63 (r2 = 0.724) where the weight is in kg and the length is in cm. This equation yields weights that are approximately 15% higher than those calculated by Ling and Bryden (1981) for animals of similar lengths. DISCUSSION The drug combinations used in this study were relatively safe and practical for repeatedly immobilizing the southern elephant seal for prolonged periods. However, dose rates of ketamine HC1 were considerably higher than those recommended for other pinnipeds (Briggs et a!., 1975; Geraci et al., 1981; Parry et al., 1981; Trillmich, 1983; Gales, 1984; Baker and Gatesman, 1985). Also, they were higher than those reported for the southern elephant seal (Ryding, 1982). Two reasons are advanced. Firstly, the point of immobilization was considered as a more profound level of anesthesia in this versus other studies. This is reflected in the relatively long induction times. Secondly, in order to roll a seal weighing up to 2 tons onto its back to measure fat thickness and body circumference it must be deeply anesthetized. This physical manipulation itself can effectively reduce the period of immobilization and thus require an increased total dose. The mean dose of ketamine HC1 used per hr and the recovery time per kg of ketamine HG! was significantly higher for the animals on Heard Island than those from the Vestfold Hills (t-test, P < 0.0005). The reason for this is that most of the total dose was required for induction, the post induction maintenance dose being low. Prolonged anaesthesia therefore results in reduced hourly dose rates. The remote method of drug administration (Ryding, 1982) worked well. Despite Ryding s (1982) suggestion that water or air could be used to flush the drug through the tube, water was used in all cases in this study because air was found to leave an unmeasurable residue of un-

GALES AND BURTON-IMMOBILIZA11ON OF SOUTHERN ELEPHANT SEALS 617 injected drug. In temperatures below 0 C care had to be exercised to prevent freezing of the drugs. The large surface area of the tube resulted in the remote system becoming unworkable at temperatures <15 C because ice blocked the tube. The positioning of the needle in the dorsal hip area proved important. If the needle was pressed into the muscle off the vertical it would commonly be dislodged. A second attempt at approaching the seal adds greatly to the difficulty of the procedure. A small barb on the needle would help alleviate this problem. Despite immobilizing seals for prolonged periods in temperatures as low as -23 C signs of hypothermia were not observed. This is not surprising as ketamine HC1, when used with diazepam, is not known to significantly alter cardiovascular or metabolic function (Soma, 1971; Green, 1979). Furthermore, the natural somnolent behavior of this species during the moult is not dissimilar to the artificially induced chemical immobilization. However, as body temperature was not monitored some change in core or skin temperature may have occurred and future studies should consider monitoring this parameter. Six elephant seals in this study tolerated two episodes of immobilization without any problems. There was no significant difference between the doses of anesthetic used. Only two seals were immobilized on three occasions and one of these (167) required approximately twice as much ketamine HG! for induction and maintenance as the remaining animals. Because both of these seals also exhibited clinical disease as a possible result of multiple immobilizations, it seems that prolonged anesthetization of the southern elephant seal on more than two occasions is contraindicated, if the intervening period is relatively short. For this reason, the data from the third anesthetic of these two seals was not used in the calculations of mean doses given in the results. We believe the fatality that occurred in this study (328) was the result of the induction dose of anesthetic being injected intravenously. Although care was taken to avoid this eventuality, the necessary haste with which the animals were injected made it impossible to be sure the needle had not been introduced into a vein. Small maintenance doses of ketamine HC1, when given intravenously, were noted to have an almost immediate effect on other seals. Thus, the rapid intravenous administration of a dose three or four times as large may well have proven fatal. Intravenous injections of ketamine HC1 were not used routinely for top up doses during prolonged anesthesia because, despite the reported advantages of rapid onset of effect and lower dose rates, the duration of effects was reduced and the response to injection less predictable. Diazepam and xylazine HC1 both proved to be suitable combinative drugs with ketamine HG!. Neither appeared superior, with both effectively preventing any of the reported side effects of ketamine HC1 immobilization seen in other pinnipeds (Geraci et a!., 1981). However, Ryding (1982) noted no such side effects when using ketamine HG! to immobilize the southern elephant seal, so combinative drugs may not be necessary. The technique devised to weigh the seals proved appropriate for animals weighing up to 2 tons. However, the equipment was very large and weighed in excess of 100 kg. This, combined with the fact that up to five field assistants were necessary for the weighing procedure, limited the technique s field use. Animals on a beach adjacent to the station were selected to reduce this problem. The discrepancy that exists between the length/weight relationship found in this study and that reported by Ling and Bryden (1981) highlights the enormous variations in body weight that the male southern elephant seals undergo during the terrestrial phase of their life cycle. Ele-

618 JOURNAL OF WILDLIFE DISEASES, VOL. 23, NO. 4, OCTOBER 1987 phant seals at the Vestfold Hills were found to lose an average of 25% of their body weight during the moult (unpubl. data). Therefore, workers estimating body weights of these seals for drug doses should consider the animal s physiological state. ACKNOWLEDGMENTS The authors would like to thank the 1985 Heard Island Australian National Antarctic Research Expedition personnel and the 1986 Davis Australian National Antarctic Research Expedition personnel for assistance in the field; K. Jestrimski, Pharmacy section, Royal Hobart Hospital for preparation of the ketamine HC1; and M. Bryden for critically reviewing the manuscript. LITERATURE CITED BAKER, J. H., AND T. J. GATESMAN. 1985. Use of carfentanil and a ketamine-xylazine mixture to immobilize wild grey seals Halichoerus grypus. Veterinary Record 116: 208-210. BRu;GS, C. D., H. V. HENRICKSON, AND B. J. LE BOEUF. 1975. Ketamine immobilization of northern elephant seals. Journal of the American Veterinary Medical Association 167: 546-548. CARRICK, R. S., E. CSORDAS, AND S. E. INGHAM. 1962. Studies on the southern elephant seal Mirounga leonina (L.) IV. Breeding and development. CSIRO Wildlife Research 7: 161-197. GALES, N. J. 1984. Ketamine HC1 and diazepam anesthesia of a leopard seal Hydrurga leptonyx for the biopsy of multiple fibromatous epulis. Australian Veterinary Journal 61: 295-296. AND H. H. BURTON. 1987. Ultrasonic measurement of blubber thickness of the southern elephant seal, Mirounga leonina (Linn.). Australian Journal of Zoology 35: 207-217. GERACI, J. H., K. SKIRNISS0N, AND D. J. ST. AUBIN. 1981. A safe method for repeatedly immobilizing seals. Journal of the American Veterinary Medical Association 179: 1192-1193. GREEN, C. J. 1979. Animal anesthesia. Laboratory Animals Ltd., London, England, pp. 229-235. INGHAM, S. E. 1957. Elephant seals on the Antarctic continent. Nature 180: 1215-1216. LING, J. K., AND M. M. BRYDEN. 1981. Southern elephant seal Mirounga leonina Linnaeus, 1758. In Handbook of marine mammals, H. J. Harrison and S. H. Hidgway (eds.). Academic Press, Inc., New York, New York, pp. 297-327. PARRY, K., S. S. ANDERSON, AND M. A. FEDAK. 1981. Chemical immobilization of gray seals. The Journal of Wildlife Management 45: 986-990. RYDING, F. N. 1982. Ketamine immobilization of southern elephant seals by a remote method. British Antarctic Survey Bulletin 57: 21-26. SoslA, L. H. 1971. Textbook of veterinary anesthesia. Williams and Wilkins Co., Baltimore, Maryland, 147 pp. TIERNEY, T. J. 1977. The southern elephant seal, Mirounga leonina (L.), in the Vestfold Hills, Antarctica. Australian Wildlife Research 4: 13-24. TRILLMICH, F. 1983. Ketamine xylazine combination for the immobilisation of Galapagos sea lions and fur seals. Veterinary Record 112: 280-297. Received for publication 25 February 1987.